Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Riethmuller, G; Klein, CA
   Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients
   SEMINARS IN CANCER BIOLOGY
   
   G. Riethmuller e C.A. Klein, "Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients", SEM CANC B, 11(4), 2001, pp. 307-311
2. Raum, T; Gruber, R; Riethmuller, G; Kufer, P
   Anti-self antibodies selected from a human IgD heavy chain repertoire: a novel approach to generate therapeutic human antibodies against tumor-associated differentiation antigens
   CANCER IMMUNOLOGY IMMUNOTHERAPY
   
   T. Raum et al., "Anti-self antibodies selected from a human IgD heavy chain repertoire: a novel approach to generate therapeutic human antibodies against tumor-associated differentiation antigens", CANCER IMMU, 50(3), 2001, pp. 141-150
3. Blazar, M; Briaire-De Bruijn, IH; Rees-Bakker, HAM; Prins, FA; Helfrich, W; de Leij, L; Riethmuller, G; Alberti, S; Warnaar, SO; Fleuren, GJ; Litvinov, SV
   Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions
   MOLECULAR AND CELLULAR BIOLOGY
   
   M. Blazar et al., "Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions", MOL CELL B, 21(7), 2001, pp. 2570-2580
4. Weckermann, D; Muller, P; Wawroschek, F; Harzmann, R; Riethmuller, G; Schlimok, G
   Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: Detection and prognostic value
   JOURNAL OF UROLOGY
   
   D. Weckermann et al., "Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: Detection and prognostic value", J UROL, 166(2), 2001, pp. 699-704
5. Borchmann, P; Riethmuller, G; Engert, A
   Monoclonal antibodies: Development and clinical perspective
   INTERNIST
   
   P. Borchmann et al., "Monoclonal antibodies: Development and clinical perspective", INTERNIST, 42(6), 2001, pp. 803
6. Maletz, K; Kufer, P; Mack, M; Raum, T; Pantel, K; Riethmuller, G; Gruber, R
   Bispecific single-chain antibodies as effective tools for eliminating epithelial cancer cells from human stem cell preparations by redirected cell cytotoxicity
   INTERNATIONAL JOURNAL OF CANCER
   
   K. Maletz et al., "Bispecific single-chain antibodies as effective tools for eliminating epithelial cancer cells from human stem cell preparations by redirected cell cytotoxicity", INT J CANC, 93(3), 2001, pp. 409-416
7. Hempel, D; Muller, P; Oruzio, D; Behr, W; Brockmeyer, C; Wochner, M; Ehnle, S; Riethmuller, G; Schlimok, G
   Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells
   CYTOTHERAPY
   
   D. Hempel et al., "Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells", CYTOTHERAPY, 2(4), 2000, pp. 287-295
8. Zippelius, A; Lutterbuse, R; Riethmuller, G; Pantel, K
   Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells
   CLINICAL CANCER RESEARCH
   
   A. Zippelius et al., "Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells", CLIN CANC R, 6(7), 2000, pp. 2741-2750
9. Braun, S; Pantel, K; Muller, P; Janni, W; Hepp, F; Kentenich, CRM; Gastroph, S; Wischnik, A; Dimpfl, T; Kindermann, G; Riethmuller, G; Schlimok, G
   Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
   NEW ENGLAND JOURNAL OF MEDICINE
   
   S. Braun et al., "Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.", N ENG J MED, 342(8), 2000, pp. 525-533
10. Gruber, R; van Haarlem, LJM; Warnaar, SO; Holz, E; Riethmuller, G
    The human antimouse immunoglobulin response and the anti-idiotypic networkhave no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A
    CANCER RESEARCH
    
    R. Gruber et al., "The human antimouse immunoglobulin response and the anti-idiotypic networkhave no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A", CANCER RES, 60(7), 2000, pp. 1921-1926
11. Loffler, A; Kufer, P; Lutterbuse, R; Zettl, F; Daniel, PT; Schwenkenbecher, JM; Riethmuller, G; Dorken, B; Bargou, RC
    A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes
    BLOOD
    
    A. Loffler et al., "A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes", BLOOD, 95(6), 2000, pp. 2098-2103
12. Braun, S; Hepp, F; Kentenich, CRM; Janni, W; Pantel, K; Riethmuller, G; Willgeroth, F; Sommer, HL
    Monoclonal antibody therapy with Edrecolomab in breast cancer patients: Monitoring of elimination of disseminated cytokeratin-positive tumor cells inbone marrow
    CLINICAL CANCER RESEARCH
    
    S. Braun et al., "Monoclonal antibody therapy with Edrecolomab in breast cancer patients: Monitoring of elimination of disseminated cytokeratin-positive tumor cells inbone marrow", CLIN CANC R, 5(12), 1999, pp. 3999-4004
13. Schakel, K; Poppe, C; Mayer, E; Federle, C; Riethmuller, G; Rieber, EP
    M-DC8+leukocytes - A novel human dendritic cell population
    PATHOBIOLOGY
    
    K. Schakel et al., "M-DC8+leukocytes - A novel human dendritic cell population", PATHOBIOLOG, 67(5-6), 1999, pp. 287-290
14. Weckermann, D; Muller, P; Wawroschek, F; Krawczak, G; Riethmuller, G; Schlimok, G
    Micrometastases of bone marrow in localized prostate cancer: Correlation with established risk factors
    JOURNAL OF CLINICAL ONCOLOGY
    
    D. Weckermann et al., "Micrometastases of bone marrow in localized prostate cancer: Correlation with established risk factors", J CL ONCOL, 17(11), 1999, pp. 3438-3443
15. Riethmuller, G; Klein, CA; Pantel, K
    Hunting down the seminal cells of clinical metastases
    IMMUNOLOGY TODAY
    
    G. Riethmuller et al., "Hunting down the seminal cells of clinical metastases", IMMUNOL TOD, 20(7), 1999, pp. 294-296
16. Klein, CA; Schmidt-Kittler, O; Schardt, JA; Pantel, K; Speicher, MR; Riethmuller, G
    Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    C.A. Klein et al., "Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells", P NAS US, 96(8), 1999, pp. 4494-4499
17. Offner, S; Schmaus, W; Witter, K; Baretton, GB; Schlimok, G; Passlick, B; Riethmuller, G; Pantel, K
    p53 gene mutations are not required for early dissemination of cancer cells
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    S. Offner et al., "p53 gene mutations are not required for early dissemination of cancer cells", P NAS US, 96(12), 1999, pp. 6942-6946
18. RIETHMULLER G; HOLZ E; SCHLIMOK G; SCHMIEGEL W; RAAB R; HOFFKEN K; GRUBER R; FUNKE I; PICHLMAIER H; HIRCHE H; BUGGISCH P; WITTE J; PICHLMAYR R
    MONOCLONAL-ANTIBODY THERAPY FOR RESECTED DUKES-C COLORECTAL-CANCER - 7-YEAR OUTCOME OF A MULTICENTER RANDOMIZED TRIAL
    Journal of clinical oncology
    
    G. Riethmuller et al., "MONOCLONAL-ANTIBODY THERAPY FOR RESECTED DUKES-C COLORECTAL-CANCER - 7-YEAR OUTCOME OF A MULTICENTER RANDOMIZED TRIAL", Journal of clinical oncology, 16(5), 1998, pp. 1788-1794
19. PANTEL K; PASSLICK B; VOGT J; STOSIEK P; ANGSTWURM M; SEENHIBLER R; HAUSSINGER K; THETTER O; IZBICKI JR; RIETHMULLER G
    REDUCED EXPRESSION OF PLAKOGLOBIN INDICATES AN UNFAVORABLE PROGNOSIS IN SUBSETS OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
    Journal of clinical oncology
    
    K. Pantel et al., "REDUCED EXPRESSION OF PLAKOGLOBIN INDICATES AN UNFAVORABLE PROGNOSIS IN SUBSETS OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER", Journal of clinical oncology, 16(4), 1998, pp. 1407-1413
20. ZIPPELIUS A; RIETHMULLER G; PANTEL K
    REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION AND ISLET-CELL CARCINOMA - NOT ANTAGONIST, BUT COMPLEMENTARY TOOLS - REPLY
    Journal of clinical oncology
    
    A. Zippelius et al., "REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION AND ISLET-CELL CARCINOMA - NOT ANTAGONIST, BUT COMPLEMENTARY TOOLS - REPLY", Journal of clinical oncology, 16(2), 1998, pp. 806-807
21. MALO A; ROMMEL F; BOGNER J; GRUBER R; SCHRAMM W; GOEBEL FD; RIETHMULLER G; WANK R
    LACK OF PROTECTION FROM HIV-INFECTION BY THE MUTANT HIV CORECEPTOR CCR5 IN INTRAVENOUSLY HIV-INFECTED HEMOPHILIA PATIENTS
    Immunobiology
    
    A. Malo et al., "LACK OF PROTECTION FROM HIV-INFECTION BY THE MUTANT HIV CORECEPTOR CCR5 IN INTRAVENOUSLY HIV-INFECTED HEMOPHILIA PATIENTS", Immunobiology, 198(4), 1998, pp. 485-488
22. RIETHMULLER G; KUFER P
    MINIMAL RESIDUAL CANCER - A TARGET FOR ANTIBODY-BASED STRATEGIES
    Naunyn-Schmiedeberg's archives of pharmacology
    
    G. Riethmuller e P. Kufer, "MINIMAL RESIDUAL CANCER - A TARGET FOR ANTIBODY-BASED STRATEGIES", Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 13-13
23. BORELLI S; SCHADENDORF D; RIETHMULLER G; PANTEL K
    IMMUNOHISTOCHEMICAL DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF MELANOMA PATIENTS
    Journal of investigative dermatology
    
    S. Borelli et al., "IMMUNOHISTOCHEMICAL DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF MELANOMA PATIENTS", Journal of investigative dermatology, 110(4), 1998, pp. 719-719
24. Schakel, K; Mayer, E; Federle, C; Schmitz, M; Riethmuller, G; Rieber, EP
    A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    K. Schakel et al., "A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes", EUR J IMMUN, 28(12), 1998, pp. 4084-4093
25. BRAUN S; MULLER M; HEPP F; SCHLIMOK G; RIETHMULLER G; PANTEL K
    MICROMETASTATIC BREAST-CANCER CELLS IN BONE-MARROW AT PRIMARY SURGERY- PROGNOSTIC VALUE IN COMPARISON WITH NODAL STATUS
    Journal of the National Cancer Institute
    
    S. Braun et al., "MICROMETASTATIC BREAST-CANCER CELLS IN BONE-MARROW AT PRIMARY SURGERY- PROGNOSTIC VALUE IN COMPARISON WITH NODAL STATUS", Journal of the National Cancer Institute, 90(14), 1998, pp. 1099-1100
26. HEMPEL D; ORUZIO D; MULLER P; BEHR W; BROCKMEYER C; WOCHNER M; EHNLE S; RIETHMULLER G; SCHLIMOK G
    EFFICACY OF ANTIBODY TREATMENT WITH 17 1A ON REDUCTION OF MRD AFTER COMPLETION OF HIGH-DOSE CHEMOTHERAPY WITH TRANSPLANTATION OF IN-VITRO TUMOR-CELL PURGED PBSC GRAFTS IN HIGH-RISK BREAST-CANCER PATIENTS/
    European journal of cancer
    
    D. Hempel et al., "EFFICACY OF ANTIBODY TREATMENT WITH 17 1A ON REDUCTION OF MRD AFTER COMPLETION OF HIGH-DOSE CHEMOTHERAPY WITH TRANSPLANTATION OF IN-VITRO TUMOR-CELL PURGED PBSC GRAFTS IN HIGH-RISK BREAST-CANCER PATIENTS/", European journal of cancer, 33, 1997, pp. 674-674
27. SCHENDEL DJ; OBERNEDER R; FALK CS; JANTZER P; KRESSENSTEIN S; MAGET B; HOFSTETTER A; RIETHMULLER G; NOSSNER E
    CELLULAR AND MOLECULAR ANALYSES OF MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTED AND NON-MHC-RESTRICTED EFFECTOR-CELLS RECOGNIZING RENAL-CELL CARCINOMAS - PROBLEMS AND PERSPECTIVES FOR IMMUNOTHERAPY
    Journal of molecular medicine
    
    D.J. Schendel et al., "CELLULAR AND MOLECULAR ANALYSES OF MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTED AND NON-MHC-RESTRICTED EFFECTOR-CELLS RECOGNIZING RENAL-CELL CARCINOMAS - PROBLEMS AND PERSPECTIVES FOR IMMUNOTHERAPY", Journal of molecular medicine, 75(6), 1997, pp. 400-413
28. FORNI G; PORTALEONE P; MATERA L; PECORARO M; RIETHMULLER G; JOHNSON J; SZOTZ H; HAAS I; GASPAR ML; TOSI M; COUTINHO A
    MEO,TOMMASO (1944-1997) - IN-MEMORIAM
    Research in immunology
    
    G. Forni et al., "MEO,TOMMASO (1944-1997) - IN-MEMORIAM", Research in immunology, 148(4), 1997, pp. 211-216
29. ORLIKOWSKY T; WANG ZQ; DUDHANE A; HOROWITZ H; RIETHMULLER G; HOFFMANN MK
    CYTOTOXIC MONOCYTES IN THE BLOOD OF HIV TYPE 1-INFECTED SUBJECTS DESTROY TARGETED T-CELLS IN A CD95-DEPENDENT FASHION
    AIDS research and human retroviruses
    
    T. Orlikowsky et al., "CYTOTOXIC MONOCYTES IN THE BLOOD OF HIV TYPE 1-INFECTED SUBJECTS DESTROY TARGETED T-CELLS IN A CD95-DEPENDENT FASHION", AIDS research and human retroviruses, 13(11), 1997, pp. 953-960
30. ZIPPELIUS A; KUFER P; HONOLD G; KOLLERMANN MW; OBERNEDER R; SCHLIMOK G; RIETHMULLER G; PANTEL K
    LIMITATIONS OF REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION ANALYSES FOR DETECTION OF MICROMETASTATIC EPITHELIAL CANCER-CELLS IN BONE-MARROW
    Journal of clinical oncology
    
    A. Zippelius et al., "LIMITATIONS OF REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION ANALYSES FOR DETECTION OF MICROMETASTATIC EPITHELIAL CANCER-CELLS IN BONE-MARROW", Journal of clinical oncology, 15(7), 1997, pp. 2701-2708
31. KUFER P; MACK M; GRUBER R; LUTTERBUSE R; ZETTL F; RIETHMULLER G
    CONSTRUCTION AND BIOLOGICAL-ACTIVITY OF A RECOMBINANT BISPECIFIC SINGLE-CHAIN ANTIBODY DESIGNED FOR THERAPY OF MINIMAL RESIDUAL COLORECTAL-CANCER
    Cancer immunology and immunotherapy
    
    P. Kufer et al., "CONSTRUCTION AND BIOLOGICAL-ACTIVITY OF A RECOMBINANT BISPECIFIC SINGLE-CHAIN ANTIBODY DESIGNED FOR THERAPY OF MINIMAL RESIDUAL COLORECTAL-CANCER", Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 193-197
32. KIEFERSAUER S; REITER C; EISENBURG J; DIEPOLDER HM; RIEBER EP; RIETHMULLER G; GRUBER R
    DEPLETION OF CD8(-LYMPHOCYTES BY MURINE MONOCLONAL CD8 ANTIBODIES ANDRESTORED SPECIFIC T-CELL PROLIFERATION IN-VIVO IN A PATIENT WITH CHRONIC HEPATITIS-C() T)
    The Journal of immunology
    
    S. Kiefersauer et al., "DEPLETION OF CD8(-LYMPHOCYTES BY MURINE MONOCLONAL CD8 ANTIBODIES ANDRESTORED SPECIFIC T-CELL PROLIFERATION IN-VIVO IN A PATIENT WITH CHRONIC HEPATITIS-C() T)", The Journal of immunology, 159(8), 1997, pp. 4064-4071
33. MACK M; GRUBER R; SCHMIDT S; RIETHMULLER G; KUFER P
    BIOLOGIC PROPERTIES OF A BISPECIFIC SINGLE-CHAIN ANTIBODY-DIRECTED AGAINST 17-1A (EPCAM) AND CD3 - TUMOR CELL-DEPENDENT T-CELL STIMULATION AND CYTOTOXIC ACTIVITY
    The Journal of immunology
    
    M. Mack et al., "BIOLOGIC PROPERTIES OF A BISPECIFIC SINGLE-CHAIN ANTIBODY-DIRECTED AGAINST 17-1A (EPCAM) AND CD3 - TUMOR CELL-DEPENDENT T-CELL STIMULATION AND CYTOTOXIC ACTIVITY", The Journal of immunology, 158(8), 1997, pp. 3965-3970
34. HOCHTLENVOLLMAR W; GRUBER R; BODENMULLER H; LINDEMANN F; PASSLICK B; SCHLIMOK G; PANTEL K; RIETHMULLER G
    OCCULT EPITHELIAL TUMOR-CELLS DETECTED IN BONE-MARROW BY AN ENZYME-IMMUNOASSAY SPECIFIC FOR CYTOKERATIN-19
    International journal of cancer
    
    W. Hochtlenvollmar et al., "OCCULT EPITHELIAL TUMOR-CELLS DETECTED IN BONE-MARROW BY AN ENZYME-IMMUNOASSAY SPECIFIC FOR CYTOKERATIN-19", International journal of cancer, 70(4), 1997, pp. 396-400
35. SCHIRREN CA; JUNG MC; ZACHOVAL R; DIEPOLDER H; HOFFMANN R; RIETHMULLER G; PAPE GR
    ANALYSIS OF T-CELL ACTIVATION PATHWAYS IN PATIENTS WITH LIVER-CIRRHOSIS, IMPAIRED DELAYED-HYPERSENSITIVITY AND OTHER T-CELL-DEPENDENT FUNCTIONS
    Clinical and experimental immunology
    
    C.A. Schirren et al., "ANALYSIS OF T-CELL ACTIVATION PATHWAYS IN PATIENTS WITH LIVER-CIRRHOSIS, IMPAIRED DELAYED-HYPERSENSITIVITY AND OTHER T-CELL-DEPENDENT FUNCTIONS", Clinical and experimental immunology, 108(1), 1997, pp. 144-150
36. PANTEL K; DOEBERITZ MV; IZBICKI JR; RIETHMULLER G
    DISSEMINATED TUMOR-CELLS - DIAGNOSIS, PROGNOSTIC VALUE, PHENOTYPING AND THERAPEUTIC STRATEGY
    Chirurg
    
    K. Pantel et al., "DISSEMINATED TUMOR-CELLS - DIAGNOSIS, PROGNOSTIC VALUE, PHENOTYPING AND THERAPEUTIC STRATEGY", Chirurg, 68(12), 1997, pp. 1241-1250
37. KLUTH B; HESS S; ENGELMANN H; SCHAFNITZEL S; RIETHMULLER G; FEUCHT HE
    ENDOTHELIAL EXPRESSION OF CD40 IN RENAL-CELL CARCINOMA
    Cancer research
    
    B. Kluth et al., "ENDOTHELIAL EXPRESSION OF CD40 IN RENAL-CELL CARCINOMA", Cancer research, 57(5), 1997, pp. 891-899
38. BRAUN S; HEPP F; SOMMER HL; RIETHMULLER G; PANTEL K
    HETEROGENEOUS EXPRESSION OF TUMOR-ANTIGENS ON MICROMETASTATIC BREAST-CANCER CELLS - IMPLICATIONS FOR GENETIC APPROACHES OF CANCER-IMMUNOTHERAPY
    Blood
    
    S. Braun et al., "HETEROGENEOUS EXPRESSION OF TUMOR-ANTIGENS ON MICROMETASTATIC BREAST-CANCER CELLS - IMPLICATIONS FOR GENETIC APPROACHES OF CANCER-IMMUNOTHERAPY", Blood, 90(10), 1997, pp. 4591-4591
39. BRAUN S; MULLER M; HEPP F; JANNI W; KINDERMANN G; RIETHMULLER G; PANTEL K
    OCCULT HEMATOGENOUS DISSEMINATION OF CARCINOMA-CELLS IN PATIENTS WITHOVARIAN-CANCER
    Blood
    
    S. Braun et al., "OCCULT HEMATOGENOUS DISSEMINATION OF CARCINOMA-CELLS IN PATIENTS WITHOVARIAN-CANCER", Blood, 90(10), 1997, pp. 961-961
40. PANTEL K; PUTZ E; RIETHMULLER G
    IDENTIFICATION OF NEW THERAPEUTIC TARGETS ON BONE-MARROW MICROMETASTASES
    Blood
    
    K. Pantel et al., "IDENTIFICATION OF NEW THERAPEUTIC TARGETS ON BONE-MARROW MICROMETASTASES", Blood, 90(10), 1997, pp. 1871-1871
41. HOLZ E; GRUBER R; RIETHMULLER G
    MONOCLONAL-ANTIBODIES IN CANCER-THERAPY - NEW PERSPECTIVES AFTER THE COLORECTAL-CARCINOMA TRIAL
    CLINICAL IMMUNOTHERAPEUTICS
    
    E. Holz et al., "MONOCLONAL-ANTIBODIES IN CANCER-THERAPY - NEW PERSPECTIVES AFTER THE COLORECTAL-CARCINOMA TRIAL", CLINICAL IMMUNOTHERAPEUTICS, 5(3), 1996, pp. 214-222
42. SPENGLER U; ZACHOVAL R; GALLATI H; JUNG MC; HOFFMANN R; RIETHMULLER G; PAPE G
    SERUM LEVELS AND IN-SITU EXPRESSION OF TNF-ALPHA AND TNF-ALPHA BINDING-PROTEINS IN INFLAMMATORY LIVER-DISEASES
    Cytokine
    
    U. Spengler et al., "SERUM LEVELS AND IN-SITU EXPRESSION OF TNF-ALPHA AND TNF-ALPHA BINDING-PROTEINS IN INFLAMMATORY LIVER-DISEASES", Cytokine, 8(11), 1996, pp. 864-872
43. GRUBER R; LEDERER S; BECHTEL U; LOB S; RIETHMULLER G; FEUCHT HE
    INCREASED ANTIBODY-TITERS AGAINST MYCOBACTERIAL HEAT-SHOCK PROTEIN-65IN PATIENTS WITH VASCULITIS AND ARTERIOSCLEROSIS
    International archives of allergy and immunology
    
    R. Gruber et al., "INCREASED ANTIBODY-TITERS AGAINST MYCOBACTERIAL HEAT-SHOCK PROTEIN-65IN PATIENTS WITH VASCULITIS AND ARTERIOSCLEROSIS", International archives of allergy and immunology, 110(1), 1996, pp. 95-98
44. GRUBER R; PFORTE A; BEER B; RIETHMULLER G
    DETERMINATION OF GAMMA DELTA AND OTHER T-LYMPHOCYTE SUBSETS IN BRONCHOALVEOLAR LAVAGE FLUID AND PERIPHERAL-BLOOD FROM PATIENTS WITH SARCOIDOSIS AND IDIOPATHIC FIBROSIS OF THE LUNG/
    APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    
    R. Gruber et al., "DETERMINATION OF GAMMA DELTA AND OTHER T-LYMPHOCYTE SUBSETS IN BRONCHOALVEOLAR LAVAGE FLUID AND PERIPHERAL-BLOOD FROM PATIENTS WITH SARCOIDOSIS AND IDIOPATHIC FIBROSIS OF THE LUNG/", APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 104(3), 1996, pp. 199-205
45. PANTEL K; RIETHMULLER G
    METHODS FOR DETECTION OF MICROMETASTATIC CARCINOMA-CELLS IN BONE-MARROW, BLOOD AND LYMPH-NODES
    Onkologie
    
    K. Pantel e G. Riethmuller, "METHODS FOR DETECTION OF MICROMETASTATIC CARCINOMA-CELLS IN BONE-MARROW, BLOOD AND LYMPH-NODES", Onkologie, 19(2), 1996, pp. 181-182
46. GRUBER R; HOLZ E; RIETHMULLER G
    MONOCLONAL-ANTIBODIES IN CANCER-THERAPY
    Perspectives in mathematical logic
    
    R. Gruber et al., "MONOCLONAL-ANTIBODIES IN CANCER-THERAPY", Perspectives in mathematical logic, 18(2), 1996, pp. 243-251
47. WEISSENHORN W; CHEN YH; REITER C; FEDERLE C; WEISS EH; RIETHMULLER G; RIEBER EP
    STRUCTURAL DIVERSITY OF MONOCLONAL CD4 ANTIBODIES AND THEIR CAPACITY TO BLOCK THE HIV GP120 CD4 INTERACTION/
    Hybridoma
    
    W. Weissenhorn et al., "STRUCTURAL DIVERSITY OF MONOCLONAL CD4 ANTIBODIES AND THEIR CAPACITY TO BLOCK THE HIV GP120 CD4 INTERACTION/", Hybridoma, 15(2), 1996, pp. 117-124
48. JUNG MC; HARTMANN B; DIEPOLDER H; ZACHOVAL R; SANTANTONIO T; GERLACH T; HOFFMAN R; WACHTLER M; EICHENLAUB D; PAUMGARTNER G; RIETHMULLER G; PAPE GR
    HEPATITIS-B VIRUS ELIMINATION IS SUPPORTED BY CD4-LYMPHOCYTES WITH TH-1 LYMPHOKINE PROFILE( T)
    Hepatology
    
    M.C. Jung et al., "HEPATITIS-B VIRUS ELIMINATION IS SUPPORTED BY CD4-LYMPHOCYTES WITH TH-1 LYMPHOKINE PROFILE( T)", Hepatology, 24(4), 1996, pp. 610-610
49. PRINZ JC; MEURER M; REITER C; RIEBER EP; PLEWIG G; RIETHMULLER G
    TREATMENT OF SEVERE CUTANEOUS LUPUS-ERYTHEMATOSUS WITH A CHIMERIC CD4MONOCLONAL-ANTIBODY, CM-T412
    Journal of the American Academy of Dermatology
    
    J.C. Prinz et al., "TREATMENT OF SEVERE CUTANEOUS LUPUS-ERYTHEMATOSUS WITH A CHIMERIC CD4MONOCLONAL-ANTIBODY, CM-T412", Journal of the American Academy of Dermatology, 34(2), 1996, pp. 244-252
50. MULLER P; WECKERMANN D; RIETHMULLER G; SCHLIMOK G
    DETECTION OF GENETIC ALTERATIONS IN MICROMETASTATIC CELLS IN BONE-MARROW OF CANCER-PATIENTS BY FLUORESCENCE IN-SITU HYBRIDIZATION
    Cancer genetics and cytogenetics
    
    P. Muller et al., "DETECTION OF GENETIC ALTERATIONS IN MICROMETASTATIC CELLS IN BONE-MARROW OF CANCER-PATIENTS BY FLUORESCENCE IN-SITU HYBRIDIZATION", Cancer genetics and cytogenetics, 88(1), 1996, pp. 8-16
51. PANTEL K; IZBICKI J; PASSLICK B; ANGSTWURM M; HAUSSINGER K; THETTER O; RIETHMULLER G
    FREQUENCY AND PROGNOSTIC-SIGNIFICANCE OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER WITHOUT OVERT METASTASES
    Lancet
    
    K. Pantel et al., "FREQUENCY AND PROGNOSTIC-SIGNIFICANCE OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER WITHOUT OVERT METASTASES", Lancet, 347(9002), 1996, pp. 649-653
52. DIEPOLDER HM; JUNG MC; WIERENGA E; HOFFMANN RM; ZACHOVAL R; GERLACH TJ; SCHOLZ S; HEAVNER G; RIETHMULLER G; PAPE GR
    ANERGIC TH1 CLONES SPECIFIC FOR HEPATITIS-B VIRUS (HBV) CORE PEPTIDESARE INHIBITORY TO OTHER HBV CORE-SPECIFIC CD4(-CELLS IN-VITRO() T)
    Journal of virology
    
    H.M. Diepolder et al., "ANERGIC TH1 CLONES SPECIFIC FOR HEPATITIS-B VIRUS (HBV) CORE PEPTIDESARE INHIBITORY TO OTHER HBV CORE-SPECIFIC CD4(-CELLS IN-VITRO() T)", Journal of virology, 70(11), 1996, pp. 7540-7548
53. ORUZIO D; PANTEL K; HEMPEL D; LINDEMANN F; WITTE J; PERSSON B; RIETHMULLER G; SCHLIMOK G
    EXPRESSION OF AN ANTIGEN RECOGNIZED BY C-242 MONOCLONAL, ANTIBODY ON MINIMAL RESIDUAL TUMOR-CELLS IN BONE-MARROW FROM PATIENTS WITH COLORECTAL-CANCER
    Blood
    
    D. Oruzio et al., "EXPRESSION OF AN ANTIGEN RECOGNIZED BY C-242 MONOCLONAL, ANTIBODY ON MINIMAL RESIDUAL TUMOR-CELLS IN BONE-MARROW FROM PATIENTS WITH COLORECTAL-CANCER", Blood, 88(10), 1996, pp. 3326-3326
54. PANTEL K; BRAUN S; SCHLIMOK G; RIETHMULLER G
    BIOLOGICAL HETEROGENEITY OF MICROMETASTATIC BREAST-CANCER CELLS - CLINICAL IMPLICATIONS
    Blood
    
    K. Pantel et al., "BIOLOGICAL HETEROGENEITY OF MICROMETASTATIC BREAST-CANCER CELLS - CLINICAL IMPLICATIONS", Blood, 88(10), 1996, pp. 1921-1921
55. ZIPPELIUS A; KUFER P; HONOLD G; RIETHMULLER G; PANTEL K
    LIMITATIONS OF REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION ANALYSES FOR DETECTION OF MICROMETASTATIC EPITHELIAL CANCER-CELLS IN BONE-MARROW
    Blood
    
    A. Zippelius et al., "LIMITATIONS OF REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION ANALYSES FOR DETECTION OF MICROMETASTATIC EPITHELIAL CANCER-CELLS IN BONE-MARROW", Blood, 88(10), 1996, pp. 2431-2431
56. RUMMEL MM; RIETHMULLER G; JOHNSON JP
    FUNCTION AND REGULATION OF THE ENDOTHELIAL-MELANOMA GLYCOPROTEIN MUC18
    Tissue antigens
    
    M.M. Rummel et al., "FUNCTION AND REGULATION OF THE ENDOTHELIAL-MELANOMA GLYCOPROTEIN MUC18", Tissue antigens, 48(4-II), 1996, pp. 510-510
57. RENSINGEHL A; HESS S; ZIEGLERHEITBROCK HWL; RIETHMULLER G; ENGELMANN H
    FAS APO-1 ACTIVATES NUCLEAR FACTOR KAPPA-B AND INDUCES INTERLEUKIN-6 PRODUCTION/
    Journal of inflammation
    
    A. Rensingehl et al., "FAS APO-1 ACTIVATES NUCLEAR FACTOR KAPPA-B AND INDUCES INTERLEUKIN-6 PRODUCTION/", Journal of inflammation, 45(3), 1995, pp. 161-174
58. SCHNEIDERGADICKE E; RIETHMULLER G
    PREVENTION OF MANIFEST METASTASIS WITH MONOCLONAL-ANTIBODIES - A NOVEL-APPROACH TO IMMUNOTHERAPY OF SOLID TUMORS
    European journal of cancer
    
    E. Schneidergadicke e G. Riethmuller, "PREVENTION OF MANIFEST METASTASIS WITH MONOCLONAL-ANTIBODIES - A NOVEL-APPROACH TO IMMUNOTHERAPY OF SOLID TUMORS", European journal of cancer, 31A(7-8), 1995, pp. 1326-1330
59. SCHLIMOK G; PANTEL K; LOIBNER H; FACKLERSCHWALBE I; RIETHMULLER G
    REDUCTION OF METASTATIC CARCINOMA-CELLS IN BONE-MARROW BY INTRAVENOUSLY ADMINISTERED MONOCLONAL-ANTIBODY - TOWARDS A NOVEL SURROGATE TEST TO MONITOR ADJUVANT THERAPIES OF SOLID TUMORS
    European journal of cancer
    
    G. Schlimok et al., "REDUCTION OF METASTATIC CARCINOMA-CELLS IN BONE-MARROW BY INTRAVENOUSLY ADMINISTERED MONOCLONAL-ANTIBODY - TOWARDS A NOVEL SURROGATE TEST TO MONITOR ADJUVANT THERAPIES OF SOLID TUMORS", European journal of cancer, 31A(11), 1995, pp. 1799-1803
60. PANTEL K; AIGNHERR C; KOLLERMANN J; CAPRANO J; RIETHMULLER G; KOLLERMANN MW
    IMMUNOCYTOCHEMICAL DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH UNTREATED STAGE-C PROSTATIC-CANCER
    European journal of cancer
    
    K. Pantel et al., "IMMUNOCYTOCHEMICAL DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH UNTREATED STAGE-C PROSTATIC-CANCER", European journal of cancer, 31A(10), 1995, pp. 1627-1632
61. RIETHMULLER G; SCHLIMOK G; SCHNEIDERGADICKE E; SCHMIEGEL W; RAAB R; HOFFKEN K; GRUBER R; PICHLMAIER H; HIRCHE H; PICHLMAYR R
    MONOCLONAL-ANTIBODY (MAB) TREATMENT OF RESECTED DUKES-C COLORECTAL-CARCINOMA (CRC) - A PROSPECTIVE RANDOMIZED TRIAL
    European journal of cancer
    
    G. Riethmuller et al., "MONOCLONAL-ANTIBODY (MAB) TREATMENT OF RESECTED DUKES-C COLORECTAL-CARCINOMA (CRC) - A PROSPECTIVE RANDOMIZED TRIAL", European journal of cancer, 31A, 1995, pp. 17-17
62. PANTEL K; RIETHMULLER G
    IMMUNOTHERAPEUTIC APPROACHES DIRECTED AGAINST MINIMAL RESIDUAL CANCER
    European journal of cancer
    
    K. Pantel e G. Riethmuller, "IMMUNOTHERAPEUTIC APPROACHES DIRECTED AGAINST MINIMAL RESIDUAL CANCER", European journal of cancer, 31A, 1995, pp. 87-87
63. GATH HJ; HEISSLER E; HELL B; BIER J; RIETHMULLER G; PANTEL K
    IMMUNOCYTOLOGIC DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK REGION
    International journal of oral and maxillofacial surgery
    
    H.J. Gath et al., "IMMUNOCYTOLOGIC DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK REGION", International journal of oral and maxillofacial surgery, 24(5), 1995, pp. 351-355
64. PANTEL K; RIETHMULLER G
    METHODS FOR DETECTION OF MICROMETASTATIC CARCINOMA-CELLS IN BONE-MARROW, BLOOD AND LYMPH-NODES
    Onkologie
    
    K. Pantel e G. Riethmuller, "METHODS FOR DETECTION OF MICROMETASTATIC CARCINOMA-CELLS IN BONE-MARROW, BLOOD AND LYMPH-NODES", Onkologie, 18(5), 1995, pp. 394-401
65. SCHLIMOK G; RIETHMULLER G
    MONOCLONAL-ANTIBODIES IN THE THERAPY OF MINIMALLY RESIDUAL SOLID TUMORS
    Onkologie
    
    G. Schlimok e G. Riethmuller, "MONOCLONAL-ANTIBODIES IN THE THERAPY OF MINIMALLY RESIDUAL SOLID TUMORS", Onkologie, 18(5), 1995, pp. 403-408
66. ZIPPELIUS A; HONOLD G; KUFER P; SCHLIMOK G; RIETHMULLER G; PANTEL K
    POTENTIAL AND LIMITATIONS OF RT-PCR FOR DETECTION OF ISOLATED CARCINOMA-CELLS IN BONE-MARROW
    Experimental hematology
    
    A. Zippelius et al., "POTENTIAL AND LIMITATIONS OF RT-PCR FOR DETECTION OF ISOLATED CARCINOMA-CELLS IN BONE-MARROW", Experimental hematology, 23(8), 1995, pp. 763-763
67. BRAUN S; HEPP F; MAASSEN V; KINDERMANN G; RIETHMULLER G; PANTEL K
    DETECTION OF MINIMAL RESIDUAL DISEASE IN BONE-MARROW OF PATIENTS WITHBREAST, CERVICAL, AND OVARIAN-CANCER
    Experimental hematology
    
    S. Braun et al., "DETECTION OF MINIMAL RESIDUAL DISEASE IN BONE-MARROW OF PATIENTS WITHBREAST, CERVICAL, AND OVARIAN-CANCER", Experimental hematology, 23(8), 1995, pp. 763-763
68. BRAUN S; ANGSTWURM M; KUTTER D; VOGT J; SCHMAUS W; SCHLIMOK G; RIETHMULLER G; PANTEL K
    PHENOTYPE OF DISSEMINATED CARCINOMA-CELLS IN BONE-MARROW
    Experimental hematology
    
    S. Braun et al., "PHENOTYPE OF DISSEMINATED CARCINOMA-CELLS IN BONE-MARROW", Experimental hematology, 23(8), 1995, pp. 764-764
69. HOFFMANN RM; DIEPOLDER HM; ZACHOVAL R; ZWIEBEL FM; JUNG MC; SCHOLZ S; NITSCHKO H; RIETHMULLER G; PAPE GR
    MAPPING OF IMMUNODOMINANT CD4(-LYMPHOCYTE EPITOPES OF HEPATITIS-C VIRUS ANTIGENS AND THEIR RELEVANCE DURING THE COURSE OF CHRONIC INFECTION() T)
    Hepatology
    
    R.M. Hoffmann et al., "MAPPING OF IMMUNODOMINANT CD4(-LYMPHOCYTE EPITOPES OF HEPATITIS-C VIRUS ANTIGENS AND THEIR RELEVANCE DURING THE COURSE OF CHRONIC INFECTION() T)", Hepatology, 21(3), 1995, pp. 632-638
70. MACK M; RIETHMULLER G; KUFER P
    A SMALL BISPECIFIC ANTIBODY CONSTRUCT EXPRESSED AS A FUNCTIONAL SINGLE-CHAIN MOLECULE WITH HIGH TUMOR-CELL CYTOTOXICITY
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    M. Mack et al., "A SMALL BISPECIFIC ANTIBODY CONSTRUCT EXPRESSED AS A FUNCTIONAL SINGLE-CHAIN MOLECULE WITH HIGH TUMOR-CELL CYTOTOXICITY", Proceedings of the National Academy of Sciences of the United Statesof America, 92(15), 1995, pp. 7021-7025
71. MENSSEN A; TROMMLER P; VOLLMER S; SCHENDEL D; ALBERT E; GURTLER L; RIETHMULLER G; PLEWIG G; PRINZ JC
    EVIDENCE FOR THE INVOLVEMENT OF A COMMON ANTIGEN IN THE PATHOGENESIS OF PSORIASIS-VULGARIS
    Journal of investigative dermatology
    
    A. Menssen et al., "EVIDENCE FOR THE INVOLVEMENT OF A COMMON ANTIGEN IN THE PATHOGENESIS OF PSORIASIS-VULGARIS", Journal of investigative dermatology, 105(3), 1995, pp. 455-455
72. PRINZ JC; MEURER M; PLEWIG G; RIETHMULLER G
    TERM FOLLOW-UP OF 5 PATIENTS WITH CUTANEOUS LUPUS-ERYTHEMATOSUS TREATED WITH A CHIMERIC CD4 MONOCLONAL-ANTIBODY
    Journal of investigative dermatology
    
    J.C. Prinz et al., "TERM FOLLOW-UP OF 5 PATIENTS WITH CUTANEOUS LUPUS-ERYTHEMATOSUS TREATED WITH A CHIMERIC CD4 MONOCLONAL-ANTIBODY", Journal of investigative dermatology, 105(3), 1995, pp. 458-458
73. MENSSEN A; TROMMLER P; VOLLMER S; SCHENDEL D; ALBERT E; GURTLER L; RIETHMULLER G; PRINZ JC
    EVIDENCE FOR AN ANTIGEN-SPECIFIC CELLULAR IMMUNE-RESPONSE IN SKIN-LESIONS OF PATIENTS WITH PSORIASIS-VULGARIS
    The Journal of immunology
    
    A. Menssen et al., "EVIDENCE FOR AN ANTIGEN-SPECIFIC CELLULAR IMMUNE-RESPONSE IN SKIN-LESIONS OF PATIENTS WITH PSORIASIS-VULGARIS", The Journal of immunology, 155(8), 1995, pp. 4078-4083
74. FLIEGER D; GRUBER R; SCHLIMOK G; REITER C; PANTEL K; RIETHMULLER G
    A NOVEL NONRADIOACTIVE CELLULAR CYTOTOXICITY TEST BASED ON THE DIFFERENTIAL-ASSESSMENT OF LIVING AND KILLED TARGET AND EFFECTOR-CELLS
    Journal of immunological methods
    
    D. Flieger et al., "A NOVEL NONRADIOACTIVE CELLULAR CYTOTOXICITY TEST BASED ON THE DIFFERENTIAL-ASSESSMENT OF LIVING AND KILLED TARGET AND EFFECTOR-CELLS", Journal of immunological methods, 180(1), 1995, pp. 1-13
75. SCHUCHMANN M; HESS S; BUFLER P; BRAKEBUSCH C; WALLACH D; PORTER A; RIETHMULLER G; ENGELMANN H
    FUNCTIONAL DISCREPANCIES BETWEEN TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN-ALPHA EXPLAINED BY TRIMER STABILITY AND DISTINCT RECEPTOR INTERACTIONS
    European Journal of Immunology
    
    M. Schuchmann et al., "FUNCTIONAL DISCREPANCIES BETWEEN TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN-ALPHA EXPLAINED BY TRIMER STABILITY AND DISTINCT RECEPTOR INTERACTIONS", European Journal of Immunology, 25(8), 1995, pp. 2183-2189
76. HESS S; KURRLE P; LAUFFER L; RIETHMULLER G; ENGELMANN H
    A CYTOTOXIC CD40 P55 TUMOR-NECROSIS-FACTOR RECEPTOR HYBRID DETECTS CD40 LIGAND ON HERPESVIRUS SAIMIRI-TRANSFORMED T-CELLS/
    European Journal of Immunology
    
    S. Hess et al., "A CYTOTOXIC CD40 P55 TUMOR-NECROSIS-FACTOR RECEPTOR HYBRID DETECTS CD40 LIGAND ON HERPESVIRUS SAIMIRI-TRANSFORMED T-CELLS/", European Journal of Immunology, 25(1), 1995, pp. 80-86
77. KRAUSS S; KUFER P; FEDERLE C; TABASZEWSKI P; WEISS E; RIEBER EP; RIETHMULLER G
    RECOMBINANT CD4-IGE, A NOVEL HYBRID MOLECULE, INDUCING BASOPHILS TO RESPOND TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) AND HIV-INFECTED TARGET-CELLS
    European Journal of Immunology
    
    S. Krauss et al., "RECOMBINANT CD4-IGE, A NOVEL HYBRID MOLECULE, INDUCING BASOPHILS TO RESPOND TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) AND HIV-INFECTED TARGET-CELLS", European Journal of Immunology, 25(1), 1995, pp. 192-199
78. PANTEL K; DICKMANNS A; ZIPPELIUS A; KLEIN C; SHI J; HOECHTLENVOLLMAR W; SCHLIMOK G; WECKERMANN D; OBERNEDER R; FANNING E; RIETHMULLER G
    ESTABLISHMENT OF MICROMETASTATIC CARCINOMA CELL-LINES - A NOVEL SOURCE OF TUMOR-CELL VACCINES
    Journal of the National Cancer Institute
    
    K. Pantel et al., "ESTABLISHMENT OF MICROMETASTATIC CARCINOMA CELL-LINES - A NOVEL SOURCE OF TUMOR-CELL VACCINES", Journal of the National Cancer Institute, 87(15), 1995, pp. 1162-1168
79. LOONEY JE; WILLINGER A; LIN G; RIEBER EP; RIETHMULLER G; GHRAYEB J
    EXPRESSION AND CHARACTERIZATION OF CM-T413, A CHIMERIC ANTI-CD4 ANTIBODY WITH IN-VITRO IMMUNOSUPPRESSIVE ACTIVITY
    Journal of immunotherapy with emphasis on tumor immunology
    
    J.E. Looney et al., "EXPRESSION AND CHARACTERIZATION OF CM-T413, A CHIMERIC ANTI-CD4 ANTIBODY WITH IN-VITRO IMMUNOSUPPRESSIVE ACTIVITY", Journal of immunotherapy with emphasis on tumor immunology, 16(1), 1994, pp. 36-46
80. GRUBER R; FELBER E; PAPE GR; HOCHTLENVOLLMAR W; RIETHMULLER G
    DETECTION OF AUTOANTIBODIES AGAINST M2, LKM-1, AND SLA IN LIVER-DISEASES BY STANDARDIZED UNIFORM ELISA-TECHNIQUES
    Journal of clinical laboratory analysis
    
    R. Gruber et al., "DETECTION OF AUTOANTIBODIES AGAINST M2, LKM-1, AND SLA IN LIVER-DISEASES BY STANDARDIZED UNIFORM ELISA-TECHNIQUES", Journal of clinical laboratory analysis, 8(5), 1994, pp. 284-292
81. PASSLICK B; IZBICKI JR; KUBUSCHOK B; NATHRATH W; THETTER O; PICHLMEIER U; SCHWEIBERER L; RIETHMULLER G; PANTEL K
    IMMUNOHISTOCHEMICAL ASSESSMENT OF INDIVIDUAL TUMOR-CELLS IN LYMPH-NODES OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
    Journal of clinical oncology
    
    B. Passlick et al., "IMMUNOHISTOCHEMICAL ASSESSMENT OF INDIVIDUAL TUMOR-CELLS IN LYMPH-NODES OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER", Journal of clinical oncology, 12(9), 1994, pp. 1827-1832
82. PANTEL K; SCHLIMOK G; BRAUN S; KUTTER D; KLEIN C; OBERNEDER R; RIESENBERG R; RIETHMULLER G
    BIOLOGY OF MICROMETASTATIC TUMOR-CELLS IN BONE-MARROW IN BREAST AND PROSTATE-CANCER
    Journal of cellular biochemistry
    
    K. Pantel et al., "BIOLOGY OF MICROMETASTATIC TUMOR-CELLS IN BONE-MARROW IN BREAST AND PROSTATE-CANCER", Journal of cellular biochemistry, 1994, pp. 244-244
83. VANDERLUBBE PA; REITER C; MILTENBURG AM; KRUGER K; DERUYTER AN; RIEBER EP; BIJL JA; RIETHMULLER G; BREEDVELD FC
    TREATMENT OF RHEUMATOID-ARTHRITIS WITH A CHIMERIC CD4 MONOCLONAL-ANTIBODY (CM-T412) - IMMUNOPHARMACOLOGICAL ASPECTS AND MECHANISMS OF ACTION
    Scandinavian journal of immunology
    
    P.A. Vanderlubbe et al., "TREATMENT OF RHEUMATOID-ARTHRITIS WITH A CHIMERIC CD4 MONOCLONAL-ANTIBODY (CM-T412) - IMMUNOPHARMACOLOGICAL ASPECTS AND MECHANISMS OF ACTION", Scandinavian journal of immunology, 39(3), 1994, pp. 286-294
84. OBERNEDER R; RIESENBERG R; KRIEGMAIR M; BITZER U; KLAMMERT R; SCHNEEDE P; HOFSTETTER A; RIETHMULLER G; PANTEL K
    IMMUNOCYTOCHEMICAL DETECTION AND PHENOTYPIC CHARACTERIZATION OF MICROMETASTATIC TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PROSTATE-CANCER
    Urological research
    
    R. Oberneder et al., "IMMUNOCYTOCHEMICAL DETECTION AND PHENOTYPIC CHARACTERIZATION OF MICROMETASTATIC TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PROSTATE-CANCER", Urological research, 22(1), 1994, pp. 3-8
85. DIEPOLDER HM; HOFFMANN RM; ZACHOVAL R; WIERENGA E; JUNG MC; KORHERR C; ZWIEBEL FM; RIETHMULLER G; PAUMGARTNER G; PAPE GR
    NONSTRUCTURAL PROTEIN-3 OF HEPATITIS-C VIRUS (HCV) IS THE MOST IMMUNOGENIC HCV ANTIGEN FOR CD4-LYMPHOCYTES IN ACUTE HEPATITIS-C( T)
    Hepatology
    
    H.M. Diepolder et al., "NONSTRUCTURAL PROTEIN-3 OF HEPATITIS-C VIRUS (HCV) IS THE MOST IMMUNOGENIC HCV ANTIGEN FOR CD4-LYMPHOCYTES IN ACUTE HEPATITIS-C( T)", Hepatology, 20(4), 1994, pp. 10000229-10000229
86. DIEPOLDER HM; JUNG MC; WIERENGA E; HOFFMANN RM; ZACHOVAL R; KORHERR C; RIETHMULLER G; PAUMGARTNER G; PAPE GR
    THE IMPORTANT NUCLEOCAPSID-SPECIFIC CD4-LYMPHOCYTE RESPONSE IN ACUTE HEPATITIS-B IS POLYCLONAL, OLIGOSPECIFIC AND DIFFERENTIALLY REGULATED(T)
    Hepatology
    
    H.M. Diepolder et al., "THE IMPORTANT NUCLEOCAPSID-SPECIFIC CD4-LYMPHOCYTE RESPONSE IN ACUTE HEPATITIS-B IS POLYCLONAL, OLIGOSPECIFIC AND DIFFERENTIALLY REGULATED(T)", Hepatology, 20(4), 1994, pp. 10000303-10000303
87. RIETHMULLER G; SCHNEIDERGADICKE E; SCHLIMOK G; SCHMIEGEL W; RAAB R; HOFFKEN K; GRUBER R; PICHLMAIER H; HIRCHE H; PICHLMAYR R; BUGGISCH P; WITTE J; EIGLER FW; FACKLERSCHWALBE I; FUNKE I; SCHMIDT CG; SCHREIBER H; SCHWEIBERER L; EIBLEIBESFELDT B
    RANDOMIZED TRIAL OF MONOCLONAL-ANTIBODY FOR ADJUVANT THERAPY OF RESECTED DUKES-C COLORECTAL-CARCINOMA
    Lancet
    
    G. Riethmuller et al., "RANDOMIZED TRIAL OF MONOCLONAL-ANTIBODY FOR ADJUVANT THERAPY OF RESECTED DUKES-C COLORECTAL-CARCINOMA", Lancet, 343(8907), 1994, pp. 1177-1183
88. MEISER BM; REITER C; REICHENSPURNER H; UBERFUHR P; KREUZER E; RIEBER EP; RIETHMULLER G; REICHART B
    CHIMERIC MONOCLONAL CD4 ANTIBODY - A NOVEL IMMUNOSUPPRESSANT FOR CLINICAL HEART-TRANSPLANTATION
    Transplantation
    
    B.M. Meiser et al., "CHIMERIC MONOCLONAL CD4 ANTIBODY - A NOVEL IMMUNOSUPPRESSANT FOR CLINICAL HEART-TRANSPLANTATION", Transplantation, 58(4), 1994, pp. 419-423
89. AHLBERG R; YI Q; PIRSKANEN R; MATELL G; SWERUP C; RIEBER EP; RIETHMULLER G; HOLM G; LEFVERT AK
    TREATMENT OF MYASTHENIA-GRAVIS WITH ANTI-CD4 ANTIBODY - IMPROVEMENT CORRELATES TO DECREASED T-CELL AUTOREACTIVITY
    Neurology
    
    R. Ahlberg et al., "TREATMENT OF MYASTHENIA-GRAVIS WITH ANTI-CD4 ANTIBODY - IMPROVEMENT CORRELATES TO DECREASED T-CELL AUTOREACTIVITY", Neurology, 44(9), 1994, pp. 1732-1737
90. ZIEGLERHEITBROCK HWL; WEDEL A; SCHRAUT W; STROBEL M; WENDELGASS P; STERNSDORF T; BAUERLE PA; HAAS JG; RIETHMULLER G
    TOLERANCE TO LIPOPOLYSACCHARIDE INVOLVES MOBILIZATION OF NUCLEAR FACTOR KAPPA-B WITH PREDOMINANCE OF P50 HOMODIMERS
    The Journal of biological chemistry
    
    H.W.L. Zieglerheitbrock et al., "TOLERANCE TO LIPOPOLYSACCHARIDE INVOLVES MOBILIZATION OF NUCLEAR FACTOR KAPPA-B WITH PREDOMINANCE OF P50 HOMODIMERS", The Journal of biological chemistry, 269(25), 1994, pp. 17001-17004
91. WANG ZQ; ORLIKOWSKY T; DUDHANE A; MITTLER R; BLUM M; LACY E; RIETHMULLER G; HOFFMANN MK
    DELETION OF T-LYMPHOCYTES IN HUMAN CD4 TRANSGENIC MICE INDUCED BY HIV-GP120 AND GP120-SPECIFIC ANTIBODIES FROM AIDS PATIENTS
    European Journal of Immunology
    
    Z.Q. Wang et al., "DELETION OF T-LYMPHOCYTES IN HUMAN CD4 TRANSGENIC MICE INDUCED BY HIV-GP120 AND GP120-SPECIFIC ANTIBODIES FROM AIDS PATIENTS", European Journal of Immunology, 24(7), 1994, pp. 1553-1557
92. BAURIEDEL G; BRILL C; BEINERT T; HOFLING B; JOHNSON J; RIETHMULLER G
    INTEGRIN DISTRIBUTION PATTERN OF HUMAN PLAQUE SMOOTH-MUSCLE CELLS - POTENTIAL IMPACT ON CELLULAR LOCOMOTION
    Circulation
    
    G. Bauriedel et al., "INTEGRIN DISTRIBUTION PATTERN OF HUMAN PLAQUE SMOOTH-MUSCLE CELLS - POTENTIAL IMPACT ON CELLULAR LOCOMOTION", Circulation, 90(4), 1994, pp. 85-85
93. BAURIEDEL G; BRILL C; BEINERT T; HOFLING B; JOHNSON J; RIETHMULLER G
    INTEGRIN DISTRIBUTION PATTERN OF HUMAN PLAQUE SMOOTH-MUSCLE CELLS - POTENTIAL IMPACT ON CELLULAR LOCOMOTION
    Circulation
    
    G. Bauriedel et al., "INTEGRIN DISTRIBUTION PATTERN OF HUMAN PLAQUE SMOOTH-MUSCLE CELLS - POTENTIAL IMPACT ON CELLULAR LOCOMOTION", Circulation, 90(4), 1994, pp. 85-85
94. SERS C; RIETHMULLER G; JOHNSON JP
    MUC18, A MELANOMA-PROGRESSION ASSOCIATED MOLECULE, AND ITS POTENTIAL ROLE IN TUMOR VASCULARIZATION AND HEMATOGENOUS SPREAD
    Cancer research
    
    C. Sers et al., "MUC18, A MELANOMA-PROGRESSION ASSOCIATED MOLECULE, AND ITS POTENTIAL ROLE IN TUMOR VASCULARIZATION AND HEMATOGENOUS SPREAD", Cancer research, 54(21), 1994, pp. 5689-5694
95. SERS C; RIETHMULLER G; JOHNSON JP
    MUC18, A MELANOMA-PROGRESSION ASSOCIATED MOLECULE, AND ITS POTENTIAL ROLE IN TUMOR VASCULARIZATION AND HEMATOGENOUS SPREAD
    Cancer research
    
    C. Sers et al., "MUC18, A MELANOMA-PROGRESSION ASSOCIATED MOLECULE, AND ITS POTENTIAL ROLE IN TUMOR VASCULARIZATION AND HEMATOGENOUS SPREAD", Cancer research, 54(21), 1994, pp. 5689-5694
96. KRAMER A; HAAS R; MUREA S; KIRSCH M; PANTEL K; RIETHMULLER G; BASTERT W; HUNSTEIN W
    MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS AND DETECTION OF MINIMAL DISEASE IN PATIENTS WITH BREAST-CANCER
    Blood
    
    A. Kramer et al., "MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS AND DETECTION OF MINIMAL DISEASE IN PATIENTS WITH BREAST-CANCER", Blood, 84(10), 1994, pp. 10000108-10000108
97. PANTEL K; SCHLIMOK G; ANGSTWURM M; SCHMAUS W; RIETHMULLER G
    IMMUNOCYTOCHEMICAL SCREENING FOR OCCULT EPITHELIAL TUMOR-CELLS IN BONE-MARROW
    Blood
    
    K. Pantel et al., "IMMUNOCYTOCHEMICAL SCREENING FOR OCCULT EPITHELIAL TUMOR-CELLS IN BONE-MARROW", Blood, 84(10), 1994, pp. 10000353-10000353
98. GRIMM T; RIETHMULLER G; JOHNSON JP
    CHARACTERISTICS OF CARCINOEMBRYONIC ANTIGEN (CEA) EXPRESSED IN DIFFERENT CELL-TYPES - EVIDENCE THAT CEA CAN FUNCTION AS AN ADHESION MOLECULE AND AS A REPULSION MOLECULE
    Biochemical and biophysical research communications
    
    T. Grimm et al., "CHARACTERISTICS OF CARCINOEMBRYONIC ANTIGEN (CEA) EXPRESSED IN DIFFERENT CELL-TYPES - EVIDENCE THAT CEA CAN FUNCTION AS AN ADHESION MOLECULE AND AS A REPULSION MOLECULE", Biochemical and biophysical research communications, 204(3), 1994, pp. 1225-1234
99. PASSLICK B; IZBICKI JR; RIETHMULLER G; PANTEL K
    P53 IN NON-SMALL-CELL LUNG-CANCER
    Journal of the National Cancer Institute
    
    B. Passlick et al., "P53 IN NON-SMALL-CELL LUNG-CANCER", Journal of the National Cancer Institute, 86(10), 1994, pp. 801-802
100. PANTEL K; KOPROWSKI H; RIETHMULLER G
     MEETING REPORT - CONFERENCE ON CANCER MICROMETASTASIS - BIOLOGY, METHODOLOGY AND CLINICAL-SIGNIFICANCE
     International journal of oncology
     
     K. Pantel et al., "MEETING REPORT - CONFERENCE ON CANCER MICROMETASTASIS - BIOLOGY, METHODOLOGY AND CLINICAL-SIGNIFICANCE", International journal of oncology, 3(5), 1993, pp. 1019-1022